When was Docturnal founded?

Docturnal was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Docturnal located?

Docturnal is headquartered in Hyderabad, India. It is registered at 171, Ravi Colony, Lal Bazar, Gunrock Avenue, Trimulgherry, Secunderabad, Telangana, India, 500015.

Which legal entities is Docturnal associated with?

Docturnal is associated with DOCTURNAL PRIVATE LIMITED.

How many employees does Docturnal have?

As of Jul 31, 2026, the latest employee count at Docturnal is 4.

Is Docturnal a funded company?

Docturnal is a funded company, having raised a total of $92.3K across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 26, 2017.

How much is Docturnal worth?

The latest valuation of Docturnal is $***** as of Oct 16, 2019. This marks a decline of 26% from its peak valuation of $853K in Jan, 2017. This marks a decline of 26% from its peak valuation of $853K in Jan, 2017.

When was the latest funding round of Docturnal?

Docturnal's latest funding was a $***** Seed round on Oct 16, 2019, with participation from 9 investors. Its primary sector is Healthcare IT. In India, the Healthcare IT sector has seen $73.6M in funding in 2026 to date.

What is the annual revenue of Docturnal?

Annual revenue of Docturnal is less than ₹10 Cr as on Mar 31, 2025

Where does Docturnal rank among its competitors?

Docturnal ranks 2nd amongst 16 active competitors, of which 6 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Medsensio, which secured $81.3K in Jun, 2023.

Who are the top competitors of Docturnal?

Docturnal's top competitors include Ubenwa, ResApp Health and RESPINOR. Among them, Medsensio secured the most recent funding round in June, 2023.

Docturnal - 2026 Company Profile, Team, Funding, Competitors & Financials

Docturnal is a seed company based in Hyderabad (India), founded in 2016. It operates as a Provider of non-invasive solutions for the detection, care screening, and diagnostics of tuberculosis. Docturnal has raised $92.3K in funding from investors like Purple Ventures, Axilor Ventures and AIRmaker, with a current valuation of $*****. The company has 16 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Ubenwa, ResApp Health and RESPINOR.

Company Details

Provider of non-invasive solutions for the detection, care screening, and diagnostics of tuberculosis. It offers TimBre which is a TB Screening app, which can detect the sound of a cough of an individual which is recorded by doctors and can be used for real-time diagnosis. It also ahs other solutions for CoPD and Asthma that can be identified with an aural / acoustics component.

Website: docturnal.com
Social
Email ID: *****@docturnal.com
Phone Number: +91 **********
Registered Address: 171, Ravi Colony, Lal Bazar, Gunrock Avenue, Trimulgherry, Secunderabad, Telangana, India, 500015

Key Metrics

Founded Year

2016

Location

Hyderabad, India

Stage

Seed

Total Funding

$92.3K in 4 rounds

Latest Funding Round

Seed, Oct 16, 2019, $*****

Post Money Valuation

$***** as on Oct 16, 2019

Investors

Purple Ventures & 25 more

Ranked

2^nd among 16 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

4 as on Jul 31, 2026

Similar Companies

Ubenwa & 14 more

View Docturnal's full profile

Docturnal is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DOCTURNAL PRIVATE LIMITED CIN: U85190TG2016PTC109301 , India, Active	Apr 29, 2016	0 - ₹10 Cr (As on Mar 31, 2025)	-

Docturnal has raised a total funding of $92.3K over 4 rounds. Its first funding round was on Jan 26, 2017. Its latest funding round was a Seed round on Oct 16, 2019 for $*****. 9 investors participated in its latest round. Docturnal has 13 institutional investors and 13 angel investors.

Here is the list of recent funding rounds of Docturnal:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 16, 2019	7814129	Seed	2057001	3180898	8984071	8212149
Sep 25, 2018	6877070	Seed	2613228	8917985	5155183	Akshay Mittal & 11 more
Aug 03, 2017	6676192	Seed	1943558	6261926	AIRmaker	2106317

Access funding benchmarks and valuations. Sign up today!

View details of Docturnal's funding rounds and investors

Docturnal's Board of Directors

Docturnal's board has 4 active members. Vaishnavi Gutha, Arpita Singh and Rahul Pathri are part of team and Balakrishna Bagadi is independent board member.

Here is the list of Docturnal's board of directors:

Name	Type	Representing	Status	Duration
Rahul Pathri	Team	-	Current	10y 4m
pnvbivm	Team	-	Past	8y 3m
ieerixa	Team	-	Past	1y 2m
Balakrishna Bagadi	Independent board member	-	Current	10y 4m

Docturnal's employee count trend

Docturnal has 4 employees as of Jul 26. Here is Docturnal's employee count trend over the years:

Uncover Docturnal's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Docturnal include Ubenwa, ResApp Health and RESPINOR. Here is the list of Top 10 competitors of Docturnal, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ubenwa 2022, Montreal (Canada), Seed	Provider of AI-based diagnostic application platform for newborns	$2.5M	Radical Ventures, AIX Ventures & 5 others	49/100
2nd	Docturnal 2016, Hyderabad (India), Seed	Provider of non-invasive solutions for the detection, care screening, and diagnostics of tuberculosis	$92.3K	Astir Ventures, Social Alpha & 24 others	39/100
3rd	ResApp Health 2010, Brisbane (Australia), Acquired	Digital disease diagnosis tool for providers	-	Fidelity, Startup Creasphere & 3 others	35/100
4th	RESPINOR 2015, Oslo (Norway), Seed	Provider of diaphragm monitoring medical device for decision making	-	EIC Fund, Europa & 1 others	34/100
5th	Ibrum Technologies 2015, Bengaluru (India), Funding Raised	Developer of device to identify undiagnosed cardiac and respiratory diseases	-	HDFC Bank, Startup Karnataka & 4 others	34/100
6th	Zana 2017, Karlsruhe (Germany), Funding Raised	Developer of software platforms extracting digital biomarkers from human voice	-	Venture Day, Start-up BW	32/100
7th	Tambua Health 2017, Fremont (United States), Seed	Software for sound based cardiopulmonary disease diagnosis	$125K	Ventures Platform, Y Combinator & 5 others	31/100
8th	Medsensio 2017, Tromso (Norway), Seed	Platform to improve respiratory diagnostics	-	Norinnova, Europa & 1 others	29/100
9th	Swaasa 2017, Hyderabad (India), Seed	AI based respiratory health diagnosis tool for providers	-	T-Hub & 3 others	26/100
10th	AI4LUNGS 2024, Porto (Portugal), Unfunded	AI based platform offerign personalized care for respiratory diseases	-	-	25/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Docturnal's competitors? Click here to see the top ones

Founders (largest shareholder) own 71.60%, Funds own 6.09%, Angels own 11.06% and Other People own 0.74%. The net worth of Docturnal's founders is INR 3.26Cr as of Oct 16, 2019.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	71.60%	3.26Cr	7307998	8387360	5226766	2848275
Fund	6.09%	27.7L	818245	678886	419119	773808
Axilor Ventures	88	92	87	83	83	37
Purple Ventures	7	3	7	6	3	3
CIE IIITH	6	3	6	7	3	1
Angel	11.06%	50.2L	8598299	7473043	6937621	1700879
Akshay Mittal	6	1	6	4	2	5
Abhijeet Birewar	7	1	5	5	6	3
Other People	0.74%	3.37L	0	0	0	0
ESOP Pool	10.54%	48L	4200151	1330443	3385302	2371398
Total	100.00%	4.55Cr	6008758	1402784	2296444	2660785